🔗 Share this article

Texas Attorney General Paxton is suing the producers of Tylenol, asserting the corporations concealed safety concerns that the pain reliever posed to children's cognitive development.

This legal action comes a month after Donald Trump promoted an unproven link between using Tylenol - also known as acetaminophen - while pregnant and autism spectrum disorder in children.

The attorney general is taking legal action against Johnson & Johnson, which previously sold the drug, the exclusive pain medication suggested for women during pregnancy, and Kenvue, which now manufacturers it.

In a statement, he stated they "deceived the public by gaining financially from pain and marketing drugs ignoring the potential hazards."

The company asserts there is lacking scientific proof connecting acetaminophen to autism spectrum disorder.

"These companies lied for decades, knowingly endangering countless individuals to boost earnings," the attorney general, from the Republican party, said.

The company said in a statement that it was "seriously troubled by the perpetuation of misinformation on the safety of acetaminophen and the potential impact that could have on the health of American women and children."

On its online platform, Kenvue also said it had "regularly reviewed the applicable studies and there is no credible data that demonstrates a established connection between taking acetaminophen and autism spectrum disorder."

Organizations acting on behalf of physicians and healthcare providers concur.

The leading OB-GYN organization has declared acetaminophen - the key substance in acetaminophen - is a restricted selection for women during pregnancy to treat discomfort and fever, which can present major wellness concerns if left untreated.

"In over twenty years of research on the consumption of acetaminophen in gestation, not a single reputable study has successfully concluded that the consumption of paracetamol in any period of pregnancy leads to brain development issues in offspring," the organization said.

This legal action cites latest statements from the previous government in claiming the medication is reportedly hazardous.

In recent weeks, Trump caused concern from public health officials when he told pregnant women to "fight like hell" not to use acetaminophen when ill.

The US Food and Drug Administration then published an announcement that doctors should think about restricting the consumption of acetaminophen, while also mentioning that "a causal relationship" between the medication and autism spectrum disorder in children has not been established.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had pledged in spring to undertake "comprehensive study program" that would identify the cause of autism in a matter of months.

But authorities cautioned that discovering a single cause of autism spectrum disorder - believed by scientists to be the result of a complicated interplay of genetic and environmental factors - would prove challenging.

Autism is a category of enduring cognitive variation and disability that influences how persons perceive and interact with the world, and is diagnosed using physician assessments.

In his court filing, the attorney general - a Trump ally who is campaigning for US Senate - alleges Kenvue and J&J "willfully ignored and tried to quiet the science" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the corporations "eliminate any promotional materials" that states Tylenol is safe for expectant mothers.

The court case parallels the complaints of a collection of mothers and fathers of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the makers of Tylenol in recently.

A federal judge threw out the legal action, saying investigations from the parents' expert witnesses was lacking definitive proof.